Gamified visual training with occlusion for kids with anisometropic amblyopia
Official title: An Exploratory Study on the Short-Term Additive Efficacy and User Experience of Innovative Gamified Intervention as an Adjunctive Therapy for Children With Monocular Anisometropic Amblyopia
Run by Xinhua Hospital, Shanghai Jiao Tong University School of Medicine · NCT07472231 · Data updated 2026-11-12
This trial tests two kid-friendly digital games plus patching to see if they improve vision and motivation in children aged 4–7 with anisometropic amblyopia compared with patching alone.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 4 Years to 7 Years |
| Sex | All |
| Enrollment | 66 (estimated) |
| Sponsor | Xinhua Hospital, Shanghai Jiao Tong University School of Medicine Academic / other |
| Locations | 1 site (Shanghai, Shanghai Municipality) |
| Status | Recruiting |
| Started | May 1, 2026 |
| Main results expected | December 2026 |
| Study ends | December 2026 |
| Registry record updated | July 30, 2026 |
| Trial ID | NCT07472231 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Children aged 4–7 with monocular anisometropic amblyopia who can cooperate with exams and the training regimen and whose guardians consent.
✕Probably not a fit
Children who do not respond to occlusion therapy or have conditions excluding participation may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional study compares a gamified visual training program combined with occlusion therapy to traditional occlusion therapy by itself in children with monocular anisometropic amblyopia. The approach uses two specially designed digital games, one serious touchscreen game and one augmented-reality game, to train visual function through parent–child interaction in home or other real-world settings. Outcomes will include changes in visual function, intrinsic motivation, and emotion regulation, assessed before and after the intervention. The goal is to develop a personalized, engaging home-based training product and service system that reduces medical anxiety and improves treatment adherence and overall clinical experience.
Why it matters
Potential benefit: If successful, children may see improved visual function and a more engaging, easier-to-follow treatment experience.
How similar studies have gone: Prior studies using gamified or AR-based visual training have shown promise, but results vary and this approach remains relatively novel in this exact setting.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Clinically diagnosed with monocular anisometropic amblyopia. 2. Aged 4 to 7 years. 3. Able to cooperate with all examinations and comply with the amblyopia training regimen. 4. Provided signed informed consent. Exclusion Criteria: 1. Severe developmental delay or cognitive impairment. 2. Serious systemic diseases. 3. Presence of organic ocular diseases (e.g., cataract, fundus diseases) or manifest strabismus. 4. Participation in any other eye-related interventional trial within the past 4 weeks.
Where it's running
-
Xin Hua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Shanghai, Shanghai Municipality, China Recruiting
Study contacts
- Study coordinator: Jianing Ren
- Email: 981433535@qq.com
- Phone: +86 18800253186
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Psilocybin-assisted therapy to help adults with amblyopia see more clearly
This study tests whether a single or small doses of psilocybin can boost the effectiveness of amblyopia treatment in adults.
-
Augmented Reality Binocular Therapy for Adult Amblyopia
This trial tests a home-based augmented reality binocular therapy to see if it improves vision in adults 18–40 with anisometropic amblyopia, compared with placebo training.
-
Gabor-based visual training for adults with amblyopia
This study tests a computer-based Gabor training program to see if it can improve vision in adults aged 18–39 with amblyopia due to anisometropia or strabismus.
-
Noninvasive brain stimulation plus augmented reality vision therapy for anisometropic amblyopia in adults
This trial tests whether adding HD-tDCS to AR-based dichoptic therapy can improve vision in adults with anisometropic amblyopia.
-
tDCS for paediatric amblyopia
This study tests whether non-invasive brain stimulation (tDCS) can improve vision for children aged 4–14 with amblyopia who didn’t get enough help from patching.
-
Combined fluoxetine and patching to improve and maintain vision in amblyopia using OCTA and VEP
This project will test whether adding fluoxetine to standard eye patching helps improve and maintain vision in people over 10 with amblyopia.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.